AKR1A1 and atrial fibrillation: In addition, a notable increase in liver weight and the liver-to-body weight ratio was recorded in AF-treated Akr1a1−/− mice, accompanied by a striking decrease in their epididymal fat weight and epididymal fat-to-body weight ratio (Supplementary Table S5).